XHKG
8437
Market cap1mUSD
Feb 13, Last price
0.15HKD
Name
RMH Holdings Ltd
Chart & performance
P/E
—
P/S
0.32
EPS
—
Vol. 1Y
—
Shs. 5Y
-35.78%
Rev. 5Y
-6.93%
Div Yld LY
—
Div Yld TTM
—
Revenues
5m
+58.62%
Net income
-4m
L-48.05%
CFO
114k
-85.40%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
RMH Holdings Limited, an investment holding company headquartered in Singapore and incorporated in 2017, delivers a diverse range of medical, dermatological, and aesthetic products and services across Singapore, Hong Kong, and international markets. The company operates through two primary segments: Healthcare Service and Trading Sales. Its healthcare division specializes in comprehensive care for dermatological conditions affecting the skin, hair, and nails, employing medical, surgical, laser, and aesthetic treatments. This includes addressing issues such as skin cancer, eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts, in addition to providing consultancy, prescription, and dispensing services. The trading segment focuses on the distribution of health supplements and various medical products, including hand sanitizers, disposable medical masks, and other essential medical supplies. RMH Holdings manages an extensive network of facilities, comprising seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||